Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00039195 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2002 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

Lymphoma, Large B-Cell, Diffuse

More general conditions related to this trial

Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

filgrastim
rituximab
carboplatin
cyclophosphamide
doxorubicin hydrochloride
etoposide
ifosfamide
prednisone
vincristine sulfate
radiation therapy

Additional drug interventions recognized in this trial

Doxorubicin
Vincristine

Sponsors listed in this trial

Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content